Eric Lefebvre is listed as an executive officer on 4 SEC Form D filings by 1 issuer between Jul 2018 and Mar 2020: PLIANT THERAPEUTICS, INC. (South San Francisco, CA — biotechnology — 2018–2020; $100.4M reported sold to 66 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bernard Coulie (4 shared filings), Charles Homcy (4 shared filings), Hoyoung Huh (4 shared filings), Johannes Hull (4 shared filings), John Curnutte (4 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Eric. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Eric Lefebvre and found 2 differences: Form D filed 21 days after the first sale; Offering amount changed between filings.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.